Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Rubenstein

Showing results (131-140 of 135) with videos related to

Pageof 14
Sort By:
You have reached the last page of results.This site can display upto 135 results.
NIDA Research Monograph|May 1, 1976
Determination of THC and its metabolites by EMIT homogeneous enzyme immunoassay: a summary reportG L Rowley, T A Armstrong, C P Crowl, et al.
Heliyon|April 5, 2021
Clinical assessment of the use of topical liquid diclofenac following laser microporation of cutaneous neurofibromas in individuals with neurofibromatosis type 1Lisa Brauer Oliveira, Mauro Geller, Karin Soares Cunha, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 30, 2013
Therapeutic potential of HSP90 inhibition for neurofibromatosis type 2Karo Tanaka, Ascia Eskin, Fabrice Chareyre, et al.
The Journal of Prosthetic Dentistry|July 28, 2005
Osseointegrated craniofacial implants in the rehabilitation of orbital defects: an update of a retrospective experience in the United StatesJoseph A Toljanic, Steven E Eckert, Eleni Roumanas, et al.
Journal of Neurogenetics|September 19, 2000
Advances in neurofibromatosis 2 (NF2): a workshop reportD J Lim, A E Rubenstein, D G Evans, et al.
Pageof 14

Showing results (131-140 of 135) with videos related to

Sort By:
Pageof 14
You have reached the last page of results.This site can display upto 135 results.
NIDA Research Monograph|May 1, 1976
Determination of THC and its metabolites by EMIT homogeneous enzyme immunoassay: a summary reportG L Rowley, T A Armstrong, C P Crowl, et al.
Heliyon|April 5, 2021
Clinical assessment of the use of topical liquid diclofenac following laser microporation of cutaneous neurofibromas in individuals with neurofibromatosis type 1Lisa Brauer Oliveira, Mauro Geller, Karin Soares Cunha, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 30, 2013
Therapeutic potential of HSP90 inhibition for neurofibromatosis type 2Karo Tanaka, Ascia Eskin, Fabrice Chareyre, et al.
The Journal of Prosthetic Dentistry|July 28, 2005
Osseointegrated craniofacial implants in the rehabilitation of orbital defects: an update of a retrospective experience in the United StatesJoseph A Toljanic, Steven E Eckert, Eleni Roumanas, et al.
Journal of Neurogenetics|September 19, 2000
Advances in neurofibromatosis 2 (NF2): a workshop reportD J Lim, A E Rubenstein, D G Evans, et al.
Pageof 14